NCT02802475
| Antibodies Causing Epilepsy Syndromes: The ACES Study. | No drug interventions | Not Available | Not Available | completed |
NCT04339205
| Diffusion Imaging in Acute Auto-immune Encephalitis | No drug interventions | Not Available | Not Available | unknown_status |
NCT04561557
| Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System | | treatment | 0 | recruiting |
NCT03993262
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients with Severe Autoimmune Encephalitis | | treatment | 2 | recruiting |
NCT06575153
| Phase 1 Study of ART5803 in Healthy Participants | | other | 1 | recruiting |
NCT06609044
| Long-term Impact of NMDAR Encephalitis | No drug interventions | Not Available | Not Available | not_yet_recruiting |
NCT05825690
| BRIEF TITLE * (in English and Sufficiently Descriptive) Role of MRI in Anti-LGI1 Encephalitis | No drug interventions | Not Available | Not Available | completed |
NCT05422664
| Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy | | Not Available | Not Available | enrolling_by_invitation |
NCT06443333
| National, Multicentric Registry Study on Neuroimmunological Diseases in China | No drug interventions | Not Available | Not Available | recruiting |
NCT05225883
| GWAS in NMDAR Encephalitis | No drug interventions | Not Available | Not Available | recruiting |
NCT03835728
| Efficacy of Ocrelizumab in Autoimmune Encephalitis | | treatment | 2 | terminated |
NCT04823728
| HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part II | No drug interventions | Not Available | Not Available | recruiting |
NCT05772611
| Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes | No drug interventions | Not Available | Not Available | recruiting |
NCT03194815
| IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2 | | treatment | 2 | recruiting |
NCT06502015
| Biomarkers in Autoimmune Disease of Nervous System | No drug interventions | Not Available | Not Available | not_yet_recruiting |
NCT04372615
| The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis | | treatment | 2 | recruiting |
NCT05280600
| Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis | No drug interventions | Not Available | Not Available | recruiting |
NCT02905136
| Mechanisms of Auto-immune Encephalitis | No drug interventions | Not Available | Not Available | completed |
NCT06456736
| Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU Treatment | No drug interventions | Not Available | Not Available | not_yet_recruiting |
NCT04175522
| Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: | No drug interventions | treatment | 2 | completed |
NCT04708626
| Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in Sweden | No drug interventions | Not Available | Not Available | completed |
NCT05953974
| Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune Origin | No drug interventions | Not Available | Not Available | active_not_recruiting |
NCT05728931
| New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes | No drug interventions | Not Available | Not Available | active_not_recruiting |
NCT06173076
| A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis | No drug interventions | Not Available | Not Available | recruiting |
NCT06079294
| Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism | No drug interventions | basic_science | Not Available | recruiting |
NCT03530462
| To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI | | Not Available | Not Available | completed |
NCT06432803
| Metabolic Imaging for Diagnosis and Prognostication of Autoimmune encephalitiS | No drug interventions | Not Available | Not Available | active_not_recruiting |
NCT03872284
| Neuro-ophthalmology and Autoimmune Encephalitis (NODE) | No drug interventions | Not Available | Not Available | recruiting |
NCT03542279
| Immunotherapy in Autoimmune Encephalitis | No drug interventions | treatment | Not Available | recruiting |
NCT05783947
| Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies | No drug interventions | Not Available | Not Available | completed |
NCT06584045
| Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis) | | treatment | Not Available | not_yet_recruiting |
NCT03004209
| Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients | | treatment | 4 | withdrawn |
NCT05645185
| Characterisation of Clinical Phenotypes and Outcomes of Ma2 Patient | No drug interventions | Not Available | Not Available | completed |
NCT06019975
| FDG-PET in the Diagnosis of Autoimmune Encephalitis | No drug interventions | Not Available | Not Available | recruiting |
NCT05741619
| Long-term Follow up of Patient With Anti-GABAbr Antibodies Associated-encephalitis. | No drug interventions | Not Available | Not Available | completed |
NCT03957616
| Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis | No drug interventions | Not Available | Not Available | unknown_status |
NCT04106596
| HLA Analysis in Autoimmune Encephalitis and Related Disorders | No drug interventions | Not Available | Not Available | unknown_status |
NCT05711563
| Predicting and Monitoring Outcomes in Autoimmune Encephalitis | No drug interventions | Not Available | Not Available | not_yet_recruiting |
NCT05177939
| Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis | | treatment | 3 | recruiting |
NCT04339127
| Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis | No drug interventions | Not Available | Not Available | unknown_status |
NCT06033846
| Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis | | treatment | 2 | recruiting |
NCT06388161
| Neural Autoantibody Prevalence in New-onset Focal Seizures of Unknown Etiology | No drug interventions | Not Available | Not Available | recruiting |
NCT04653571
| CASPR2 Encephalitis Initial Symptoms | No drug interventions | Not Available | Not Available | completed |